FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:1188-1190 September 18, 2003 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Lardinois, D. PubMed Citation

To the Editor: Lardinois et al. (June 19 issue)¹ state that the accuracy of positron-emission tomography (PET) in lymph-node staging is only 49 percent. At least 15 patients had N0 disease on tumor–node–metastasis staging (i.e., IA or IB disease). If it is assumed that at least in these patients, the findings were correctly interpreted as negative, then apparently the PET evaluation was correct in only 3 of the remaining 22 node-positive patients, whereas the findings in most of the node-positive patients were interpreted as equivocal. This poor accuracy of PET in nodal staging contrasts with the results of all previous . . . [Full Text of this Article]

This article has been cited by other articles:

• Pozo-Rodriguez, F., Martin de Nicolas, J. L., Sanchez-Nistal, M. A., Maldonado, A., Garcia de Barajas, S., Calero-Garcia, R., Pozo, M. A., Martin-Escribano, P., Martin-Garcia, I., Garcia-Lujan, R., Lopez-Encuentra, A., Arenas de Pablo, A. (2005). Accuracy of Helical Computed Tomography and [18F] Fluorodeoxyglucose Positron Emission Tomography for Identifying Lymph Node Mediastinal Metastases in Potentially Resectable Non-Small-Cell Lung Cancer. JCO 23: 8348-8356 [Abstract] [Full Text]